phorbolol myristate acetate has been researched along with u 0126 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, J; Shimada, M | 1 |
| Chen, G; Ghosh, P; Longo, DL | 1 |
2 other study(ies) available for phorbolol myristate acetate and u 0126
| Article | Year |
|---|---|
Timing of MAP kinase inactivation effects on emission of polar body in porcine oocytes activated by Ca2+ ionophore.
Topics: Animals; Butadienes; Calcimycin; Calcium; CDC2 Protein Kinase; Female; Ionophores; Male; Mitogen-Activated Protein Kinases; Nitriles; Oocytes; Protein Kinase Inhibitors; Sperm Injections, Intracytoplasmic; Swine; Tetradecanoylphorbol Acetate; Time Factors | 2005 |
Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors.
Topics: Blotting, Western; Butadienes; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Resistance; Enzyme Activation; Enzyme Inhibitors; HEK293 Cells; Humans; MAP Kinase Kinase 1; Nitriles; Protein Binding; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Signal Transduction; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta1 | 2011 |